References
- Jabben N, Arts B, van OJ, Krabbendam L. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder. J Clin Psychiatry 2010;71:764–74.
- Bell M, Tsang HW, Greig TC, Bryson GJ. Neurocognition, social cognition, perceived social discomfort, and vocational outcomes in schizophrenia. Schizophr Bull 2009;35:738–47.
- Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006;67:e12.
- Sadock BJ, Sadock VA, Ruiz P. Comprehensive textbook of psychiatry. 9th ed. Lippincott Williams and Wilkins; 2009.
- Manoach DS, Gollub RL, Benson ES, Searl MM, Goff DC, Halpern E, . Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry 2000;48:99–109.
- Tanaka S. Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective. Neuroscience 2006;139:153–71.
- Castner SA, Williams GV, Goldman-Rakic PS. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 2000;287:2020–2.
- Diaz FJ, James D, Botts S, Maw L, Susce MT, De Leon J. Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. Bipolar Disorders 2009;11:154–65.
- Kotov R, Guey LT, Bromet EJ, Schwartz JE. Smoking in Schizophrenia: Diagnostic Specificity, Symptom Correlates, and Illness Severity. Schizophrenia Bulletin 2010;36:173–81.
- Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, . A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. J Clin Psychopharmacol 2007;27:380–6.
- Sharifi V, Assadi SM, Mohammadi MR, Amini H, Kaviani H, Semnani Y, . Structured clinical interview for DSM-VI (SCID): Persian translation and cultural adaptation. Iran J Psychiatry 2007;1:46–8.
- Benedict RHB. Brief visuospatial memory test-revised (BVMT-R), Professional Manual. 4th ed. Florida: Psychological assessment resources; 1997.
- Benedict RHB, Schretlen D, Groninger L, Dobraski M, Shpritz B. Revision of the brief visuospatial memory test: studies of normal performance, reliability, and validity. Psychological Assessment 1996;8:145–53.
- Callicott JH, Ramsey NF, Tallent K, Bertolino A, Knable MB, Coppola R, . Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology 1998;18:186–96.
- Levin ED, Simon BB. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 1998;138:217–30.
- Nisell M, Nomikos GG, Hertel P, Panagis G, Svensson TH. Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse 1996 Apr;22(4):369–81.
- Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B, . Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 2004;29:1378–85.
- Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, . Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 2005;62:649–59.
- Patel NH, Vyas NS, Puri BK, Nijran KS, Al-Nahhas A. Positron emission tomography in schizophrenia: a new Perspective. J Nucl Med 2010;51:511–20.
- Calkins ME, Gur RC, Ragland JD, Gur RE. Face recognition memory deficits and visual object memory performance in patients with schizophrenia and their relatives. Am J Psychiatry 2005;162:1963–6.
- Hofer A, Weiss EM, Golaszewski SM, Siedentopf CM, Brinkhoff C, Kremser C, . An FMRI study of episodic encoding and recognition of words in patients with schizophrenia in remission. Am J Psychiatry 2003;160:911–8.
- Myers CS, Robles O, Kakoyannis AN, Sherr JD, Avila MT, Blaxton TA, . Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology (Berl) 2004;174:334–40.
- Jubelt L, Barr R, Goff D, Logvinenko T, Weiss A, Evins A. Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia. Psychopharmacology 2008;199:89–98.